| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/20/2006 | CN1276080C Method for fish gene in site modification breeding |
| 09/19/2006 | US7110890 Auto-analysis framework for sequence evaluation |
| 09/19/2006 | US7110808 Method of optimizing radiosurgery and radiotherapy with metalloporphyrins |
| 09/19/2006 | US7110803 Device and method for determining analyte levels |
| 09/19/2006 | US7110585 Nanoparticle imaging system and method |
| 09/19/2006 | US7109856 Wheel lifted and grounded identification for an automotive vehicle |
| 09/19/2006 | US7109394 Methods for modulating floral organ identity, modulating floral organ number, increasing of meristem size, and delaying flowering time |
| 09/19/2006 | US7109318 Nucleic acids encoding PRO830 |
| 09/19/2006 | US7109316 New class of nucleoside triphosphates that contain an oligonucleotide of random or defined sequence attached to the base and are substrates for polymerases and terminal nucleotidyl transferases is described |
| 09/19/2006 | US7109314 Fluorescent nucleotides |
| 09/19/2006 | US7109294 Identifying compounds which alter sensitivity of a microorganism to microbicidal agents; drug screening |
| 09/19/2006 | US7109293 System for detecting protease |
| 09/19/2006 | US7109167 Tetrapeptide |
| 09/19/2006 | US7109044 Determining the concentration of albumin in a urine sample of a test subject to be normal; determining a concentration of human lipocalin-type prostaglandin D synthase (L-PGDS) then in a urine sample taken from the same test subject; comparing |
| 09/19/2006 | US7109036 Hematology reference control containing an immature granulocyte component |
| 09/19/2006 | US7109033 Methods of identifying an agent that modulates the activity of a plant stress-regulated regulatory element, and methods of determining whether a plant has been exposed to a stress |
| 09/19/2006 | US7109027 Aβ-Peptide screening assay |
| 09/19/2006 | US7109021 Can be used for the treatment of diabetes or for delaying the onset of diabetes |
| 09/19/2006 | US7109012 Recombinant lysophosphatidic acid phosphatase |
| 09/19/2006 | US7109011 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases |
| 09/19/2006 | US7109010 Isolated nucleic acid encoding a yeast lactate dehydrogenate protein; use in production of lactic acid |
| 09/19/2006 | US7109009 Comprises nucleotide sequences coding enzymatic polypeptide for producing intermediates associated with thermoplastics, plasticizing agents, lubricants, hydraulic fluids, dyes, agricultural hemicals, pharmaceuticals and adhesives |
| 09/19/2006 | US7109008 L-glutamate oxidase |
| 09/19/2006 | US7108997 Identifying myeloperoxidase modulator via decrease in hypochlorous acid conversion into chloramine; for treating nervous system, atherosclerotic, cancer, respiratory and inflammatory disorders |
| 09/19/2006 | US7108996 Using enhanced luciferase as reporter molecule to monitor molecular events in biology, biochemistry, immunology and cell biology |
| 09/19/2006 | US7108994 Identifying a compound that modulates phosphotyrosine phosphatase activity of a polypeptide by incuabating togetjer and measuring activity of enzyme |
| 09/19/2006 | US7108992 Detecting activated kinase in sample; obtain sample containing kinase, determine phosphorylation state of serine, phosphorylation of preferential serine indicates active state |
| 09/19/2006 | US7108989 Therapy |
| 09/19/2006 | US7108988 Methods of identifying agents for inhibiting lentivirus replication |
| 09/19/2006 | US7108987 Factors participating in degranulation of mast cells, DNAs encoding the same, method of screening of these factors and the inhibitors |
| 09/19/2006 | US7108986 A diagnostic agent comprising a reporting molecule attached to the binding molecule for detecting human cancers |
| 09/19/2006 | US7108985 Detecting preferential peptide in sample; obtain sample, incubate with label, release peptide, analyzing the released peptides by mass spectrometry |
| 09/19/2006 | US7108982 Providing a blood sample from a subject to be tested for age-related macular degeneration; determining whether the sample has protein markers for abdominal aortic aneurysm (AAA) |
| 09/19/2006 | US7108981 Administering monoclonal antibody that specifically binds Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin-6 (vIL-6), wherein the monoclonal antibody is produced by a hybridoma in a pharmaceutically acceptable carrier for therapy of Kaposi's sarcoma-associated herpesvirus infection |
| 09/19/2006 | US7108980 Filtering a sample containing bacteria and yeast through at least one filter; treating filters with a medium which facilitates the growth of the bacteria and yeast; growing the bacteria and yeast on filters to produce colonies or microcolonies of bacteria and yeast; fixing the colonies; hybridization |
| 09/19/2006 | US7108979 Methods to detect cross-contamination between samples contacted with a multi-array substrate |
| 09/19/2006 | US7108978 Detecting the presence of a single nucleotide polymorphism in a CD81 gene (SEQ ID NO: 46) and determining that said individual has said propensity to respond effectively to said, treatment of interferon- alpha and ribavirin combined therapy if said single nucleotide polymorphism is present |
| 09/19/2006 | US7108977 Process for determining the tumoricidal potential of a sample the use of a nucleic acid which is downregulated in human tumor cells |
| 09/19/2006 | US7108976 Complexity management of genomic DNA by locus specific amplification |
| 09/19/2006 | US7108975 Atlastin |
| 09/19/2006 | US7108974 Detecting bacteria or viral nucleotide sequences; restriction fragment length polymorphism; fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS); ion trap; time of flight |
| 09/19/2006 | US7108973 Human PEN11B-related gene variant associated with lung cancers |
| 09/19/2006 | US7108972 Proteins, polynucleotides encoding them and methods of using the same |
| 09/19/2006 | US7108971 For use in hybridization/purification/immunoassays/biosensors; solid phase synthesis |
| 09/19/2006 | US7108970 Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state |
| 09/19/2006 | US7108969 Methods for detecting and diagnosing oral cancer |
| 09/19/2006 | US7108968 Mycobacterial rpoB sequences |
| 09/19/2006 | US7108967 Using immunoglobulin which binds specifically to hepatitis envelope antigens E1 and E2 to detect viral infection |
| 09/19/2006 | US7108966 Monitoring sperm migration in a forward direction and the density of active and functional sperm in sample; diagnosis and treatment of reproductive disorders |
| 09/19/2006 | US7108856 Comprise viral amino acid sequences for use in vaccine preparation and prevention of viral infection |
| 09/19/2006 | US7108778 Electrochemical sensors including electrode systems with increased oxygen generation |
| 09/19/2006 | US7107928 Selectively deformable container end closure |
| 09/19/2006 | CA2304870C Dryer-added fabric softener composition comprising chlorine scavenger to provide color and other fabric benefits |
| 09/19/2006 | CA2298181C Non-targeted complex sample analysis |
| 09/19/2006 | CA2074854C Imidazolinone resistant ahas mutants |
| 09/18/2006 | CA2501301A1 Human endogenous foamy retrovirus and uses thereof |
| 09/18/2006 | CA2501274A1 A competitive binding assay for cell surface charge |
| 09/18/2006 | CA2501253A1 Means and methods for individualized drug therapy and for predicting adverse drug reaction |
| 09/15/2006 | CA2539781A1 Methods for substrate and inhibitor screening using enzyme-reactor, chromatography/tandem mass spectrometry |
| 09/15/2006 | CA2500932A1 Methods for substrate and modulator screening using enzyme-reactor, chromatography/tandem mass spectrometry |
| 09/14/2006 | WO2006096735A2 Enhancing a luminescent signal |
| 09/14/2006 | WO2006096727A2 Methods for detecting integrated dna |
| 09/14/2006 | WO2006096704A2 Isotopically-labeled proteome standards |
| 09/14/2006 | WO2006096649A2 Methods and biomarkers for detecting nanoparticle exposure |
| 09/14/2006 | WO2006096619A2 Stabilizing the activity of pqq-dependent glucose dehydrogenase in electrochemical biosensors |
| 09/14/2006 | WO2006096561A2 Genetic variants increase the risk of age-related macular degeneration |
| 09/14/2006 | WO2006096527A2 Nucleic acids and proteins and methods for making and using them |
| 09/14/2006 | WO2006096498A2 Regulation of runx1 for treatment of pain |
| 09/14/2006 | WO2006096473A2 Identification of polynucleotides for predicting activity of compunds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells |
| 09/14/2006 | WO2006096459A2 Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 09/14/2006 | WO2006096427A2 Association between markers in the leptin gene and carcass traits in commercial feedlot steer and heifers |
| 09/14/2006 | WO2006096345A2 Coagulation and fibrinolytic cascades modulator |
| 09/14/2006 | WO2006096269A2 Targeted gene deletions for polysaccharide slime formers |
| 09/14/2006 | WO2006096224A2 A method for the simultaneous detection of hpv rna & dna in a sample |
| 09/14/2006 | WO2006096222A2 Nucleic acid ligands specific to immunoglobulin e and their use as atopic disease therapeutics |
| 09/14/2006 | WO2006096213A1 Polyamine sensors and methods of using the same |
| 09/14/2006 | WO2006096185A2 Reagentless and reusable biosensors with tunable differential binding affinites and methods of making |
| 09/14/2006 | WO2006096140A1 Methods for assessing suitability of cancer patients for treatment with histone deacetylase inhibitors |
| 09/14/2006 | WO2006096063A1 Construct and method for screening, selection and identification of stress factors |
| 09/14/2006 | WO2006096012A1 Method of de novo sequencing of peptide using the maldi mass spectrometry, method and apparatus for preparing sample for maldi mass spectrometry |
| 09/14/2006 | WO2006095985A1 Method of diagnosing breast cancer and compositions therefor |
| 09/14/2006 | WO2006095981A1 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| 09/14/2006 | WO2006095905A1 Tumor marker and diagnostic kit using the same |
| 09/14/2006 | WO2006095897A1 Screening method |
| 09/14/2006 | WO2006095896A1 Cultured cell monitoring system |
| 09/14/2006 | WO2006095846A1 Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same |
| 09/14/2006 | WO2006095758A1 Method of avoiding substrate inhibition by pqqgdh |
| 09/14/2006 | WO2006095757A1 Multilayer analytical element |
| 09/14/2006 | WO2006095723A1 Antiallergic drug |
| 09/14/2006 | WO2006095697A1 Method of detecting microorganism and bacteriolytic reagent |
| 09/14/2006 | WO2006095696A1 Method of detecting adenosine triphosphate and detection reagent therefor |
| 09/14/2006 | WO2006095674A1 Method for study, determination or evaluation |
| 09/14/2006 | WO2006095654A1 Reporter gene assay method |
| 09/14/2006 | WO2006095559A1 USE OF Fgf21 AS HEMATOPOIETIC FACTOR |
| 09/14/2006 | WO2006095550A1 Pcr primer, pcr method utilizing the same, and pcr amplified product, and device and dna-protein complex utilizing pcr amplified product |
| 09/14/2006 | WO2006095259A2 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds |
| 09/14/2006 | WO2006095195A1 Antimicrobial compounds |
| 09/14/2006 | WO2006095169A1 Method for preparing polynucleotides for analysis |
| 09/14/2006 | WO2006094836A2 Specific dnas for epigenetic characterisation of cells and tissues |
| 09/14/2006 | WO2006094798A2 Use of panel of pairs of primers complementary to reporter genes of cell differentiation |